Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVIBOOST: Pfizer vs Sanofi/GSK COVID-19 Booster Trial
NCT05124171Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Modality
- Recombinant Protein Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of monovalent [B.1.351] CoV2 preS dTM-AS03 in coronavirus disease 2019 (COVID-19), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
monovalent [B.1.351] CoV2 preS dTM-AS03
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05124171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05124171.